Back to today’s briefing

Story perspectives

UCSF Study: Extended Paxlovid Treatment Offers Hope for Long COVID

1/8/2025

50 10

Summary

Story summary

A groundbreaking UCSF study reveals that longer courses of Paxlovid could offer hope for some long COVID patients. Among 13 participants, five experienced lasting symptom relief, challenging previous findings that showed minimal benefits. Researchers urge further investigation to pinpoint which patients could gain from this treatment and determine the ideal duration for maximum effect.

1 of 1

Story summary

A groundbreaking UCSF study reveals that longer courses of Paxlovid could offer hope for some long COVID patients. Among 13 participants, five experienced lasting symptom relief, challenging previous findings that showed minimal benefits. Researchers urge further investigation to pinpoint which patients could gain from this treatment and determine the ideal duration for maximum effect.